Alprazolam reduces freezing of gait and improves freezing-related gait measures
Objective: We investigated the effect of acutely reducing anxiety with the benzodiazepine, Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD). Background:…Predictors of antidepressant and benzodiazepine treatment in Parkinson’s disease
Objective: To assess the prevalence of antidepressant and benzodiazepine (BDZ) treatment in Parkinson’s disease (PD), to analyze treatment with respect to altered mood indication, and…Spinal myoclonus in secondary progressive multiple sclerosis
Objective: We report a rare case of secondary progressive multiple sclerosis with one of the manifestation was spinal myoclonus. Background: Myoclonus is a sudden and…Potential treatment considerations for refractory REM behavior disorder
Objective: A meta-analysis of alternative treatment therapies for refractory REM behavior disorder. Background: Parkinson’s disease is a neurodegenerative syndrome that affects motor and non-motor functions.…MOVEMENT DISORDERS FEATURES ASSOCIATED WITH WEST SYNDROME
Objective: To describe the clinical, therapeutic and outcome features of movement disorders (MD) observed in children with West Syndrome (WS) at the Neurology Department of…Therapeutic potential of compounds preferring specific GABAA receptor subunits for the treatment of dystonia?
Objective: To further define the pathophysiology of the reduction of striatal interneurons in an animal model of dystonia and to develop novel therapeutic strategies targeting…Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination
Objective: To evaluate the correlation between cognitive and functional performance of Parkinsonian with normal Mini-Mental State Examination (MMSE), and demographic variables, motor impairment, neuropsychiatric disorders…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.